|
|
|
|
| LEADER |
00000cam a2200000xa 4500 |
| 001 |
b10767636 |
| 003 |
CoU |
| 005 |
20190906044435.5 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
190824s2019 sz o 001 0 eng d |
| 020 |
|
|
|a 9783030106164
|q (electronic bk.)
|
| 020 |
|
|
|a 3030106160
|q (electronic bk.)
|
| 020 |
|
|
|z 9783030106157
|
| 035 |
|
|
|a (OCoLC)spr1111980062
|
| 035 |
|
|
|a (OCoLC)1111980062
|
| 037 |
|
|
|a spr978-3-030-10616-4
|
| 040 |
|
|
|a EBLCP
|b eng
|c EBLCP
|d GW5XE
|d EBLCP
|d UIU
|
| 049 |
|
|
|a GWRE
|
| 050 |
|
4 |
|a RB155-155.8QH431QP34
|
| 245 |
0 |
0 |
|a Primordial prevention of non communicable disease
|h [electronic resource] /
|c Roya Kelishadi, editor.
|
| 260 |
|
|
|a Cham :
|b Springer,
|c 2019.
|
| 300 |
|
|
|a 1 online resource (72 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent.
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia.
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier.
|
| 490 |
1 |
|
|a Advances in Experimental Medicine and Biology ;
|v v.1121.
|
| 500 |
|
|
|a Description based upon print version of record.
|
| 505 |
0 |
|
|a Intro; Preface; Contents; 1: Life-Cycle Approach for Prevention of Non Communicable Disease; 1.1 Introduction; 1.2 Behavioral Risk Factors; 1.2.1 Tobacco Use; 1.2.2 Physical Inactivity; 1.2.3 Unhealthy Dietary Habits; 1.2.4 Exposure to Environmental Chemicals; 1.2.5 Socio Demographic Influences; 1.3 Conclusion; References; 2: Epigenetics and Common Non Communicable Disease; 2.1 Introduction; 2.2 The Role of DNA Methylation and Chromatin Modifications in Developing Cancer, Type 2 Diabetes Mellitus and Schizophrenia; 2.2.1 Cancer; 2.2.1.1 DNA Methylation.
|
| 505 |
8 |
|
|a 2.2.1.2 Chromatin Modifications2.2.2 Diabetes Mellitus; 2.2.3 Schizophrenia; 2.3 The Importance of ncRNAs as Epigenetic Mechanisms; 2.3.1 Types of ncRNA and Their Functions; 2.3.2 ncRNAs as Biomarkers in Cancer; 2.3.2.1 Cancer Diagnosis; 2.3.2.2 Tumor Classification; 2.3.2.3 Cancer Prognosis; 2.3.2.4 Prediction of Therapeutic Responses; 2.3.3 Diabetes Mellitus and ncRNAs; 2.3.4 Schizophrenia and ncRNAs; 2.4 Future Perspectives; References; 3: The Role of Environmental Disruptor Chemicals in the Development of Non Communicable Disease; 3.1 Introduction; 3.2 Overview of EDCs.
|
| 505 |
8 |
|
|a 3.2.1 EDC Categories3.2.1.1 Phthalates; 3.2.1.2 Bisphenols; 3.2.1.3 Polychlorinated Biphenyls; 3.2.1.4 Polycyclic Aromatic Hydrocarbons; 3.2.1.5 Pesticides; 3.2.2 Sources and Pathways of Exposure to EDCs; 3.3 EDCs Contributions to Major NCDs; 3.3.1 EDCs and Metabolic Diseases; 3.3.1.1 Obesity; 3.3.1.2 Diabetes; 3.3.1.3 Metabolic Syndrome; 3.3.2 Effects on the Reproductive Health; 3.3.3 EDCs and Cancer; 3.3.4 EDCs and Respiratory Diseases; 3.4 Endocrine Disrupting Mechanism of Action; 3.5 Conclusions; References; 4: Early Life Nutrition and Non Communicable Disease.
|
| 505 |
8 |
|
|a 4.1 Introduction4.2 Nutrition In Utero and Risk of NCDs in Later Life; 4.3 Maternal Macronutrient Intake and Its Influence on Appetite and Food Preferences in the Offspring; 4.4 Early Life Nutrition and Allergic Disease; 4.5 Nutrition in Early Life and Diabetes; 4.6 Nutrition in Early Life and Non-alcoholic Fatty Liver Disease (NAFLD); 4.7 Early-Life Nutritional Status and Metabolic Syndrome; 4.8 Early Life Nutrition and Cancer Risk; References; 5: Family Based Prevention of Cardiovascular Disease Risk Factors in Children by Lifestyle Change: The PEP Family Heart Study.
|
| 505 |
8 |
|
|a 5.1 Introduction5.2 Subjects and Methods; 5.3 Results; 5.3.1 Cardiovascular Risk Factors; 5.3.1.1 Family Screening; 5.3.1.2 Adolescents; 5.3.1.3 Percentage Body Fat; 5.3.1.4 Metabolic Syndrome; 5.3.1.5 Elevated Blood Pressure; 5.3.1.6 Dyslipidemia; 5.3.1.7 Overweight and obesity; 5.3.1.8 Smoking; 5.3.1.9 Low Birth Weight; 5.3.1.10 Migrants; 5.3.2 Lifestyle Change; 5.3.2.1 Healthy Nutrition; 5.3.2.2 Leisure Time Physical Activity; 5.4 Discussion; 5.4.1 International Comparisons in youths; 5.4.1.1 Children; 5.4.1.2 Adolescents; 5.4.1.3 Adults; References.
|
| 500 |
|
|
|a 6: The Growing Epidemic of Chronic Kidney Disease: Preventive Strategies to Delay the Risk for Progression to ESRD.
|
| 500 |
|
|
|a Includes index.
|
| 650 |
|
0 |
|a Medicine, Preventive.
|0 http://id.loc.gov/authorities/subjects/sh85083162.
|
| 700 |
1 |
|
|a Kelishadi, Roya.
|
| 776 |
0 |
8 |
|i Print version:
|a Kelishadi, Roya
|t Primordial Prevention of Non Communicable Disease
|d Cham : Springer,c2019
|z 9783030106157.
|
| 830 |
|
0 |
|a Advances in experimental medicine and biology ;
|v v. 1121.
|0 http://id.loc.gov/authorities/names/n42001229.
|
| 856 |
4 |
0 |
|u https://colorado.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-030-10616-4
|z Full Text (via Springer)
|
| 907 |
|
|
|a .b107676369
|b 03-19-20
|c 09-10-19
|
| 998 |
|
|
|a web
|b 09-30-19
|c b
|d b
|e -
|f eng
|g sz
|h 0
|i 1
|
| 907 |
|
|
|a .b107676369
|b 10-02-19
|c 09-10-19
|
| 944 |
|
|
|a MARS - RDA ENRICHED
|
| 907 |
|
|
|a .b107676369
|b 09-30-19
|c 09-10-19
|
| 915 |
|
|
|a I
|
| 956 |
|
|
|a Springer e-books
|
| 956 |
|
|
|b Springer Biomedical and Life Sciences eBooks 2019 English+International
|
| 999 |
f |
f |
|i af4aef0d-bd8a-58d4-9197-d22d43fce477
|s 9367cb32-b49a-552c-9f83-3d49c481ee39
|
| 952 |
f |
f |
|p Can circulate
|a University of Colorado Boulder
|b Online
|c Online
|d Online
|e RB155-155.8QH431QP34
|h Library of Congress classification
|i Ebooks, Prospector
|n 1
|
